Tips on how to manage your PhD stipend FIND OUT MORE
University of Liverpool Featured PhD Programmes
University of Sussex Featured PhD Programmes
Queen’s University Belfast Featured PhD Programmes

The role of VISTA expression by tumour macrophages in limiting the efficacy of chemotherapy and checkpoint inhibitors


Department of Oncology and Metabolism

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
Prof Claire Lewis , Dr M Muthana Applications accepted all year round Self-Funded PhD Students Only

About the Project

Women with triple negative breast cancer (TNBC) have limited treatment options and often rely heavily on chemotherapy. Unfortunately, many fail to show a complete response to this and suffer recurrence at the primary or distant sites within 1-3 years. This means that there is an urgent need to develop new ways to prevent this.

We recently identified a subset of CD206+ macrophages in chemotherapy-treated breast tumours that gather around blood vessels and drive relapse. Our latest data show that these cells are immunosuppressive and upregulate a protein called VISTA. This is a potent, broad-spectrum negative checkpoint regulator (NCR) that inhibits the anti-tumour functions of cytotoxic T cells (CTLs) in tumours. We believe that macrophages expressing high levels of VISTA in the perivascular niche of tumours after chemotherapy inhibit CTLs upon their entry into tumours, helping to protect cancer cells from destruction by the immune system, and facilitating tumour regrowth.

The PhD student will conduct experiments to see whether CD206-targeted liposomes containing an inhibitor for VISTA stimulates tumour CTLs after chemotherapy, augments anti-tumour immunity, and prevents subsequent relapse. The project will also investigate with these liposomes can augment the efficacy of checkpoint inhibitors like anti-PD1 and anti-PDL1. These new combination treatment treatments will be tested in various experimental models of TNBC and, if successful, will then progress into early-phase clinical trials for TNBC patients.

Funding Notes

Funding:
This project is open to self-funded students only.

Entry Requirements:
Candidates must have a upper second class honors degree or equivalent overseas qualification, in a relevant subject.

Enquiries:
Interested candidates should in the first instance contact (Professor Claire Lewis, +44 (0)114 215 9012 & [Email Address Removed])


References

How to apply:
Please complete a University Postgraduate Research Application form available here: www.shef.ac.uk/postgraduate/research/apply

Please clearly state the prospective main supervisor in the respective box and select 'Oncology and Metabolism' as the department.
Search Suggestions

Search Suggestions

Based on your current searches we recommend the following search filters.



FindAPhD. Copyright 2005-2021
All rights reserved.